Search

Search Results

• 

  Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

  M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

  143-166

  31-10-2013

  https://doi.org/10.4081/reumatismo.2013.143

  7082

  PDF: 2538
• 

  Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios

  O. Di Munno, A. Delle Sedie

  67-79

  https://doi.org/10.4081/reumatismo.2011.67

  1563

  PDF: 938
• 

  Glucocorticoid-induced osteoporosis: 2013 update

  M. Mazzantini, O. Di Munno

  144-152

  28-07-2014

  https://doi.org/10.4081/reumatismo.2014.787

  3582

  PDF: 2207

• Expert opinion on the management of patients with osteoporosis with anabolic drugs in Italy

  M. Rossini, F.P. Cantatore, A. Del Puente, B. Frediani, D. Gatti, S. Giannini, M. Varenna, O. Viapiana, G.D. Sebastiani

  24-06-2024

  https://doi.org/10.4081/reumatismo.2024.1696

  3136

  PDF: 1299
• 

  Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life

  G. Adami, A. Giollo, M. Rossini, G. Orsolini, C. Benini, O. Viapiana, D. Gatti, A. Fassio

  71-74

  23-07-2020

  https://doi.org/10.4081/reumatismo.2020.1267

  1526

  PDF: 1067